A possibility is that the negative control of NEAT1 over CDK5R1 levels is not efficient either because the ratio between CDK5R1 and NEAT1 typical of controls is increased in AD brains (Figure 6), or because NEAT1 loses its positive control towards miR-15/107 (Figure 7). This evidence concerns the gene CDK5R1 and Alzheimer disease.